Kaerus Bioscience
PrivateCompany Overview
Kaerus Bioscience is a biotechnology company that develops targeted therapeutics for rare neurodevelopmental disorders such as Fragile X syndrome.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
biotechnologydrug discoverysmall molecule therapeuticsneurodevelopmental disordersion channel modulatorsbiotech startupclinical stage biotechFragile X syndromeBK channelsprecision medicinedrug licensingtranslational medicineclinical trialsrare disease drug
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Kaerus Bioscience Comparables
Compare Kaerus Bioscience with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Autifony Therapeutics Limited | 86% | |
| Spinogenix, Inc. | 84% | |
| Confluence Pharmaceuticals | 84% | |
Kaerus Bioscience Funding Rounds
Historical fundraising activity
Kaerus Bioscience Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Kaerus Bioscience's valuation, stock price, and market status.
See something wrong or outdated?